Live from the NIH registry
Studies recruiting near Santa Rosa right now
Top 25 of 149 recruiting studies, sorted by proximity — each links to its official registry page
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Head and Neck Carcinoma, Adenoid Cystic Carcinoma
Phase 1, Phase 2
Interventional 242 participants sought
Providence Medical Foundation (site 209) — Santa Rosa, California (0.6 mi)
· Sponsor: VM Oncology, LLC
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Saint Helena Hospital — St. Helena, California (13.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Providence Medical Foundation - Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi)
· Sponsor: Eli Lilly and Company
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: NRG Oncology
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Saint Helena Hospital — St. Helena, California (13.4 mi)
· Sponsor: National Cancer Institute (NCI)
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: SWOG Cancer Research Network
Patient Specific Talus Spacer Post Approval Study
Avascular Necrosis of the Talus
N/A
Observational 50 participants sought
Sutter Health Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: Paragon 28
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: National Cancer Institute (NCI)
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
Phase 1, Phase 2
Interventional 340 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi)
· Sponsor: Inhibrx Biosciences, Inc
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
Complex Regional Pain Syndrome Type I
Phase 3
Interventional 270 participants sought
Ambros Clinical Trial Site — Napa, California (25.0 mi)
· Sponsor: Ambros Therapeutics, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma
Phase 2, Phase 3
Interventional 982 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi)
· Sponsor: Pfizer
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2, Phase 3
Interventional 131 participants sought
Sutter Pacific Medical Foundation — Santa Rosa, California (0.6 mi)
· Sponsor: National Cancer Institute (NCI)
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Metastatic Breast Cancer
Phase 3
Interventional 500 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi)
· Sponsor: American Society of Clinical Oncology
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
NorthBay Clinical Research — Santa Rosa, California (0.6 mi)
· Sponsor: Novo Nordisk A/S
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
Providence Medical Foundation - Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: SWOG Cancer Research Network
Molecular Optimization Via Exercise (MOVE)
Aging
N/A
Observational 80 participants sought
Buck Institute for Research on Aging — Novato, California (24.5 mi)
· Sponsor: Buck Institute for Research on Aging
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,500 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: NRG Oncology
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma
Phase 2
Interventional 156 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: National Cancer Institute (NCI)
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
Providence Medical Foundation - Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: Canadian Cancer Trials Group
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Carcinoma, Non-Small-Cell Lung
Phase 2
Interventional 480 participants sought
Providence Medical Foundation 1 — Santa Rosa, California (0.6 mi)
· Sponsor: Janssen Research & Development, LLC
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Metastatic Breast Cancer
Phase 3
Interventional 600 participants sought
Providence Medical Foundation - Santa Rosa, CA — Santa Rosa, California (0.6 mi)
· Sponsor: LeonaBio
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
Breast Cancer, Cognitive Impairments
N/A
Interventional 386 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: NRG Oncology